The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patients with moderate-to-severe ARDS the impact of early use of NMBAs on 90-day mortality, through propensity score (PS) matching analysis.

Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysisIn: CRITICAL CARE. - ISSN 1466-609X. - 26:1(2022), pp. 141.1-141.17. [10.1186/s13054-022-03983-5]

Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

D. Chiumello;G. Grasselli;
2022

Abstract

The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patients with moderate-to-severe ARDS the impact of early use of NMBAs on 90-day mortality, through propensity score (PS) matching analysis.
COVID-19; Intensive care unit; Mechanical ventilation; Neuromuscular blocking agent; SARS-CoV-2; Aged; Female; Humans; Intensive Care Units; Male; Middle Aged; Propensity Score; Respiration, Artificial; COVID-19; Neuromuscular Blocking Agents; Respiratory Distress Syndrome
Settore MED/41 - Anestesiologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
567_libassi_13054_2022_Article_3983.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.62 MB
Formato Adobe PDF
1.62 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/944797
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact